Avatrombopag API is a thrombopoietin receptor agonist indicated for the treatment of thrombocytopenia in adults with chronic liver disease or immune thrombocytopenia (ITP). It stimulates platelet production by activating the TPO receptor. Avatrombopag API is produced under GMP compliance and is suitable for oral solid dosage forms.

Avatrombopag API is manufactured and supplied by Artis Biotech | ASTANDARDS, ensuring high purity, consistent quality, and regulatory-compliant specifications. Our APIs are produced using validated processes and are suitable for research, development, and pharmaceutical manufacturing applications.